文献速递心力衰竭与心肌病高血压

妊娠期高血压疾病与远期扩张型心肌病风险

Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy.
PubMed 文献 · JAMA Cardiol · 2025-01-01

这项基于英格兰电子健康记录的人群队列研究纳入14 083例首次妊娠合并妊娠期高血压疾病患者和70 415例血压正常妊娠者,发现妊娠期高血压疾病与扩张型心肌病风险升高相关(调整后HR 1.93,95%CI 1.33-2.81),且子痫前期和重度子痫前期风险更高。

要点

  • 首次妊娠合并妊娠期高血压疾病与扩张型心肌病风险升高相关。
  • 子痫前期及重度子痫前期显示更高的扩张型心肌病风险。
  • 高龄产妇和产后高血压独立增加扩张型心肌病风险。

核心结论

  • 妊娠期高血压疾病患者发生扩张型心肌病的风险更高。
  • 高龄产妇和产后高血压与妊娠期高血压疾病后扩张型心肌病风险升高相关。

研究设计与样本

  • 基于英格兰电子健康记录数据库的人群队列研究,纳入首次妊娠合并妊娠期高血压疾病者14 083例和血压正常首次妊娠者70 415例(5:1随机抽样)。

主要发现

  • 首次妊娠合并妊娠期高血压疾病与扩张型心肌病风险升高93%相关(调整后HR 1.93,95%CI 1.33-2.81,P=.001,调整母亲年龄)。
  • 进一步调整母亲年龄、出生年份、妊娠期糖尿病、产后糖尿病、产后高血压、总产次、种族和社会经济地位后,关联仍显著(调整后HR 1.55,95%CI 1.04-2.31,P=.03)。
  • 子痫前期调整后HR 1.85(95%CI 1.24-2.76,P=.002),重度子痫前期调整后HR 4.29(95%CI 2.32-7.96,P<.001)。
  • 母亲年龄每增加1岁调整后HR 1.06(95%CI 1.03-1.08,P<.001),产后新发高血压调整后HR 1.68(95%CI 1.16-2.42,P=.006)。
  • 妊娠期高血压疾病患者扩张型心肌病中位(IQR)发生于产后5.1(0.7-10.6)年,血压正常妊娠者为产后10.6(4.2-15.8)年。

临床怎么用

  • 对有妊娠期高血压疾病史的患者应进行长期临床 vigilance,关注扩张型心肌病风险。
  • 产后高血压和较高母亲年龄可能有助于识别妊娠期高血压疾病后扩张型心肌病高风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The impact of hypertensive disorders of pregnancy on developing dilated cardiomyopathy is unknown. OBJECTIVE: To determine whether hypertensive disorders of pregnancy are associated with long-term risk of dilated cardiomyopathy. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study performed in England used the following linked electronic health records databases: Clinical Practice Research Datalink (CPRD) Pregnancy Register, CPRD Aurum (primary care), Hospital Episode Statistics Admitted Patient Care, and Office for National Statistics mortality data. Participants included an exposed cohort of 14 083 patients in their first pregnancy with hypertensive disorders of pregnancy (index date observed: January 1997 to December 2018; followed up until July 2023) and unexposed cohort of 70 415 with normotensive pregnancies randomly sampled from the Pregnancy Register (5:1 ratio). EXPOSURE: Hypertensive disorder of pregnancy (preeclampsia, gestational hypertension). MAIN OUTCOMES AND MEASURES: Cox proportional hazards models were fitted to estimate hazard ratios (HRs) of developing dilated cardiomyopathy. RESULTS: The cohort included 14 083 individuals with a hypertensive disease of pregnancy during their first pregnancy and 70 415 individuals with normotensive first pregnancies. A first-time pregnancy complicated by a hypertensive disorder of pregnancy, compared with a normotensive first-time pregnancy, was associated with a 93% higher risk of developing dilated cardiomyopathy (adjusted HR, 1.93 [95% CI, 1.33-2.81]; P = .001; adjusted for maternal age). Dilated cardiomyopathy developed a median (IQR) of 5.1 (0.7-10.6) years post partum in those with HDP and 10.6 (4.2-15.8) years post partum in those with normotensive first pregnancies. The association remained significant after adjusting for maternal age, birth year, gestational diabetes, postpregnancy diabetes, postpregnancy hypertension, total parity, ethnicity, and socioeconomic status (adjusted HR, 1.55 [95% CI, 1.04-2.31]; P = .03). There was a dose response; there was a higher risk of DCM in those with preeclampsia (adjusted HR, 1.85 [95% CI, 1.24-2.76]; P = .002) and severe preeclampsia (adjusted HR, 4.29 [95% CI, 2.32-7.96]; P < .001). Maternal age (adjusted HR per year of age, 1.06 [95% CI, 1.03-1.08]; P < .001) and postpartum incident hypertension (adjusted HR, 1.68 [95% CI, 1.16-2.42]; P = .006) were independently associated with the development of DCM. CONCLUSIONS: Patients with hypertensive disorders of pregnancy had a greater risk of developing dilated cardiomyopathy. Older maternal age and postpartum hypertension were associated with higher risk of dilated cardiomyopathy after a hypertensive disorder of pregnancy. These findings support long-term clinical vigilance of patients with a history of hypertensive disorders of pregnancy.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Tayal U, Kallis C, Massen GM, et al. Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy. JAMA Cardiol. 2025. PMID: 40172877. doi:10.1001/jamacardio.2025.0328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。